Patrick Taylor Horn net worth and biography

Patrick Horn Biography and Net Worth

Insider of Albireo Pharma

Dr. Patrick T. Horn M.D. Ph.D. serves as Chief Medical Officer of the Company. He previously served as Senior Vice President, Medical and Clinical Development at Orphan Technologies Ltd., a biopharmaceutical company, from January 2018 to July 2018. Prior to that, he served as Chief Medical Officer at Tetraphase Pharmaceuticals, Inc., a biopharmaceutical company, from January 2011 to December 2017. Prior to that, he served as Vice President, Clinical & Medical Affairs at Dyax Corporation, a biopharmaceutical company, from September 2007 to December 2010. Previously, Dr. Horn served in various positions at Abbott Laboratories, a pharmaceutical company, from 2001 to 2006, most recently serving as Medical Director, Head of Clinical Pharmacology. Dr. Horn received a B.S. in Chemistry from the University of Illinois, a Ph.D. in the Pharmacological and Physiological Sciences from the University of Chicago and an M.D. from the University of Chicago, Pritzker School of Medicine.

How do I contact Patrick Taylor Horn?: The corporate mailing address for Dr. Horn and other Albireo Pharma executives is 10 POST OFFICE SQUARE SUITE 502 SOUTH, BOSTON MA, 02109. Albireo Pharma can also be reached via phone at (857) 254-5555 and via email at [email protected]. Learn More on Patrick Taylor Horn's contact information.
Has Patrick Taylor Horn been buying or selling shares of Albireo Pharma?: Patrick Taylor Horn has not been actively trading shares of Albireo Pharma during the past quarter. Most recently, Patrick Taylor Horn sold 95 shares of the business's stock in a transaction on Friday, October 22nd. The shares were sold at an average price of $28.83, for a transaction totalling $2,738.85. Learn More on Patrick Taylor Horn's trading history.
Who are Albireo Pharma's active insiders?: Albireo Pharma's insider roster includes Ronald Cooper (CEO), Jason Duncan (Insider), Simon Harford (CFO), Patrick Horn (Insider), Jan Mattsson (Insider), and Pamela Stephenson (insider). Learn More on Albireo Pharma's active insiders.

Patrick Taylor Horn Insider Trading History at Albireo Pharma

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
10/22/2021	Sell	95	$28.83	$2,738.85
7/22/2021	Sell	90	$34.13	$3,071.70
10/22/2020	Sell	89	$34.55	$3,074.95
4/22/2020	Sell	92	$17.64	$1,622.88
1/22/2020	Sell	443	$24.29	$10,760.47

Patrick Taylor Horn Buying and Selling Activity at Albireo Pharma

Albireo Pharma Company Overview

Albireo Pharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. Its pipeline products include Odevixibat, A3384, and Elobixibat. The company was founded by Jan Peter Mattsson and Per-Göran Gillberg on December 8, 2003 and is headquartered in Boston, MA.

Today's Range

Now: $44.15

$43.99

$44.90

50 Day Range

MA: $44.17

$43.50

$44.95

2 Week Range

Now: $44.15

$16.02

$45.23

Volume

1,241,282 shs

Average Volume

704,539 shs

Market Capitalization

$913.91 million

P/E Ratio

N/A

Dividend Yield